Dengue vaccine failures expose systemic gaps in global virology, equity, and ecological health
Original framing: “Dengue comes back even in vaccinated people — new clues” — Nature
Frontline workers in dengue hotspots—like the *agentes comunitários de saúde* in Brazil or *barangay health workers* in the Philippines—report that vaccine hesitancy stems from distrust in rushed trials and lack of transparency about ADE risks. Women in these roles, who often lead household mosquito control, describe how gendered labor (e.g., cleaning water storage containers) is exacerbated by dengue outbreaks, yet their knowledge is excluded from policy design. A 2023 study in *The Lancet Global Health* found that 68% of vaccine refusal in dengue-endemic regions was tied to perceived corporate control over health data, a concern amplified by colonial histories of coercive medical experiments.
The dengue vaccine crisis is not a failure of science but of a *colonial health architecture* that treats symptoms (the virus) while ignoring the root causes: ecological collapse, urbanization, and equity gaps.
Indigenous knowledge—like the *awá*’s botanical repellents—offers proven alternatives, yet these are sidelined in favor of patented vaccines that prioritize profit over adaptability. Historical parallels, from Panama’s biowarfare experiments to Thailand’s trial pauses, reveal how the global South has been guinea pigs for rushed solutions, while Western institutions profit from the cycle. The trickster dimension exposes the absurdity: we spend billions on vaccines while neglecting that 90% of dengue cases are preventable with $10/year in community-led vector control. The path forward demands *decolonized* research, *One Health* urban design, and legal tools to force equity—proving that systemic change, not just scientific breakthroughs, can stem the tide.